CCL5 and neoplasm: Arginase-1, produced by myeloid cells, impairs antitumor response [57], and CCL5, mainly expressed by T lymphocytes, macrophages, platelets, tumor cells [58] and MDSCs, resulted in a direct CCR5-dependent recruitment of Treg cells in TME [59].